ADSSR Medicines Priority List · key takeaways
ASEAN overview
Priority assessment + national lists vs WHO Model List 23rd list · 2023
7AMS answered the priority questionnaire
10national essential medicines lists analysed
113WHO entries on every national list
16/21multi-situation priorities on ≥8 national lists
1
Commonly listed itemsAMS priorities are spread thin
Most medicines were named by only 2 AMS.
2
A shared core already exists
113 WHO entries on every list · 232 on at least 8
3
Click a countryWHO coverage by country
51% to 74% of the 502 WHO entries · median 64% (dashed)
4
Beyond the WHO list
1,113 medicines listed by AMS are not on the WHO list · most are unique to one country
→
Next steps
VerifyAMS check of NEML data, early 2027
Agree criteriafor the ASEAN Medicines Priority List
Act on gapsstockpiles, pooled procurement, reliance
Map supplyregional manufacturers & distributors
5
● = national lists including the medicine (of 10)Priorities vs national lists
Routine priorities are already widely listed. Emergency, pandemic, high-cost and shortage medicines are the gaps, where regional action adds most.
Already widely listed
Gaps: on few national lists
Essential medicines comparison
List overlap
National and WHO countsCircle areas are proportional to the counts.
No national essential medicines list. Brunei Darussalam has no NEML, so it is not part of the WHO EML comparison.
Priority assessment
Active ingredients
Regional column: how many of the 10 national lists include the itemSearch the national list and the WHO Model List entries.
| Active ingredient or list entry | List category | Regional |
|---|
Sources & method
- Priority assessment: ASEAN Regional Pharmaceutical Landscape & Priority Assessment questionnaire (after the 23 July 2025 preparatory meeting); 6 domains, ATC-coded; findings presented 8 April 2026. Counts here are items in the commonly listed (regional) lists.
- NEML analysis: 10 national lists itemised and matched both ways to the 502 entries of the WHO Model List, 23rd list (2023), one-to-many. Square-box alternatives excluded; national lists analysed as extracted.
- Counts: "Country only" in the Venn uses the working sheet; the ingredient table uses the harmonised AMS-only sheet, which merges 21 brand/salt variants (ID 2, MM 1, SG 11, TH 7). "Both lists" is counted on the national side and on the WHO side, so the two can differ.
- Status: draft. Myanmar corrected 16 Nov 2026. AMS verification planned for early 2027.